Lanean...
Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy
Metastatic castration-resistant prostate cancer is the lethal form of cancer of the prostate. Five new agents that prolong survival in this group have emerged in the past 5 years, and sipuleucel-T is among them. Sipuleucel-T is the only immunotherapy shown to improve survival in prostate cancer. It...
Gorde:
| Argitaratua izan da: | Core Evid |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4279604/ https://ncbi.nlm.nih.gov/pubmed/25565923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S54712 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|